Intelligence Feed event · Credit · 2026-09-07

    Teva launches EUR and USD senior notes to refinance high-coupon 2028-2029 debt

    Question

    Teva launches EUR and USD senior notes to refinance high-coupon 2028-2029 debt

    Direct answer

    Teva Pharmaceutical has launched a multi-currency debt offering comprising EUR and USD-denominated senior notes issued via finance subsidiaries. The refinancing directly targets high-coupon maturities. Proceeds will be applied toward the early redemption of its 6.750% 2028 notes and its 7.875% and 7.375% 2029 sustainability-linked notes, addressing looming debt walls and lowering interest burdens.

    Original publisher
    Market Ontology
    Evidence through
    2026-09-07
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Teva launches EUR and USD senior notes to refinance high-coupon 2028-2029 debt”, revision 1, evidence through 2026-09-07. https://marketontology.com/market-events/2026-09-07/teva-launches-eur-and-usd-senior-notes-to-refinance-high-coupon-2028-2029-debt-c816aa

    CREDIT
    Teva launches EUR and USD senior notes to refinance high-coupon 2028-2029 debt
    Teva Pharmaceutical has launched a multi-currency debt offering comprising EUR and USD-denominated senior notes issued via finance subsidiaries. The refinancing directly targets high-coupon maturities. Proceeds will be applied toward the early redemption of its 6.750% 2028 notes and its 7.875% and 7.375% 2029 sustainability-linked notes, addressing looming debt walls and lowering interest burdens.
    TEVA
    Impact
    69
    SEP 7
    SIG
    90%
    TEVA
    Teva launches EUR and USD senior notes to refinance high-coupon 2028-2029 debt
    Teva Pharmaceutical has launched a multi-currency debt offering comprising EUR and USD-denominated senior notes issued via finance subsidiaries. The refinancing directly targets high-coupon maturities. Proceeds will be applied toward the early redemption of its 6.750% 2028 notes and its 7.875% and 7.375% 2029 sustainability-linked notes, addressing looming debt walls and lowering interest burdens.
    → Refinancing high-coupon sustainability-linked notes lowers Teva's annual net cash interest expense and extends debt maturity profiles.
    Impact
    Teva Pharmaceutical has launched a multi-currency debt offering comprising EUR and USD-denominated senior notes issued via finance subsidiaries. The refinancing directly targets high-coupon maturities. Proceeds will be applied toward the early redemption of its 6.750% 2028 notes and its 7.875% and 7.375% 2029 sustainability-linked notes, addressing looming debt walls and lowering interest burdens.
    Affected
    TEVA
    Transmission
    Refinancing high-coupon sustainability-linked notes lowers Teva's annual net cash interest expense and extends debt maturity profiles.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    TEVAcredit spread tightening on debt maturity extension and interest expense reductionUp1-5dTeva announced an offering of senior notes to redeem existing 6.750% 2028 and 7.875%/7.375% 2029 notes.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    Price follow-up pending — no stored daily closes for these assets yet.

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month